E-mail

E-mail a Wiley Online Library Link

Hironori Yamaguchi, Joji Kitayama, Hironori Ishigami, Shigenobu Emoto, Hiroharu Yamashita and Toshiaki Watanabe A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S-1 for treatment of gastric cancer with macroscopic peritoneal metastasis Cancer 119

Version of Record online: 24 JUN 2013 | DOI: 10.1002/cncr.28204

A phase 2 study was performed to evaluate the benefits and tolerability of weekly intravenous and intraperitoneal paclitaxel treatment combined with oral S-1 in patients with gastric cancer who had macroscopic peritoneal metastasis. This combination chemotherapy was well tolerated, and the 1-year overall survival rate was 77.1%.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH